C.H. Chen's Insider Trades & SAST Disclosures
C.H. Chen's most recent trade in ACM Research Inc - Ordinary Shares - Class A was a trade of 163,308 Class A Common Stock done at an average price of $30 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern C.H. Chen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ACM Research Inc - Ordinar... | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 17 Mar 2025 | 163,308 | 100,002 (0%) | 0% | 30 | 4,899,240 | Class A Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Aug 2024 | 3,374 | 27,018 (0%) | 0% | 0 | Ordinary Shares | |
| ACM Research Inc - Ordinar... | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 20,000 | 20,000 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 318 | 9,695 | - | - | Phantom Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 455 | 9,377 | - | - | Phantom Stock Unit | |
| Zoetis Inc - Ordinary Shar... | C. Chen Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 3,169 | 0 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi Chen C. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 3,169 | 32,379 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Chen C. Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 2,108 | 1,673 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Chen C. Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2024 | 2,108 | 30,027 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | C. Heidi Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.32 per share. | 10 Feb 2024 | 1,086 | 31,293 (0%) | 0% | 197.3 | 214,290 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 197.32 per share. | 10 Feb 2024 | 817 | 29,210 (0%) | 0% | 197.3 | 161,210 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi Chen C. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 707 | 28,185 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | C. Chen Heidi | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2024 | 707 | 1,416 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | C. Chen Heidi | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 195.75 per share. | 08 Feb 2024 | 266 | 27,919 (0%) | 0% | 195.8 | 52,070 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Chen Heidi C. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 6,936 | 6,936 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | C. Heidi Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 1,803 | 1,803 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | C. Chen Heidi | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2024 | 3,169 | 3,169 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi Chen C. | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 115 | 8,922 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Chen Hubert C. | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 90,000 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2024 | 7,500 | 96,478 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert Chen C. | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.82 per share. | 01 Jan 2024 | 3,073 | 93,405 | - | 0.8 | 2,525 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2023 | 152 | 8,806 | - | - | Phantom Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 180.15 per share. | 15 Sep 2023 | 9,905 | 27,478 (0%) | 0% | 180.2 | 1,784,386 | Common Stock |
| ACM Research Inc - Ordinar... | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2023 | 24,000 | 24,000 | - | - | Stock Option | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jul 2023 | 74,257 | 84,071 | - | 1.0 | 75,000 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 133 | 8,653 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 7,500 | 12,407 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2023 | 7,500 | 105,000 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.04 per share. | 01 Jul 2023 | 2,593 | 9,814 | - | 1.0 | 2,697 | Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 1,559 | 20,426 (0%) | 0% | 0 | Ordinary Shares | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 144 | 8,519 | - | - | Phantom Stock Unit | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 7,500 | 112,500 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 7,500 | 7,500 | - | 0 | Common Stock | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 01 Apr 2023 | 2,593 | 4,907 | - | 1.0 | 2,619 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 542 | 8,375 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 779 | 18,867 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 779 | 1,559 | - | - | Restricted Stock Units | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2023 | 120,000 | 120,000 | - | - | Restricted Stock Units | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,841 | 38,385 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,841 | 0 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,299 | 36,299 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,299 | 3,748 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.33 per share. | 11 Feb 2023 | 1,002 | 37,383 (0%) | 0% | 158.3 | 158,647 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.33 per share. | 11 Feb 2023 | 755 | 35,544 (0%) | 0% | 158.3 | 119,539 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 7,834 | 7,834 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,841 | 2,841 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 2,105 | 2,105 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2023 | 139 | 7,832 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 779 | 2,338 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2022 | 779 | 18,088 (0%) | 0% | - | Ordinary Shares | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2022 | 177 | 7,693 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2022 | 377 | 0 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2022 | 377 | 17,309 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 3,117 | 3,117 | - | - | Restricted Stock Units | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 151 | 7,516 | - | - | Phantom Stock Unit | |
| ACM Research Inc - Ordinar... | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 24,000 | 24,000 | - | - | Stock Option | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 377 | 377 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 377 | 16,932 (0%) | 0% | - | Ordinary Shares | |
| Forte Biosciences Inc | Hubert C. Chen | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 388 | 7,365 | - | - | Phantom Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2022 | 898 | 6,977 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 377 | 16,555 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 377 | 754 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.92 per share. | 25 Feb 2022 | 5,555 | 16,178 (0%) | 0% | 38.9 | 216,201 | Ordinary Shares |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Feb 2022 | 5,555 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 13,025 | 0 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 13,025 | 39,678 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.87 per share. | 12 Feb 2022 | 5,678 | 34,000 (0%) | 0% | 198.9 | 1,129,184 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 3,776 | 27,871 (0%) | 0% | - | Common Stock | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2022 | 3,776 | 5,999 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 198.87 per share. | 12 Feb 2022 | 1,218 | 26,653 (0%) | 0% | 198.9 | 242,224 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 13,025 | 13,025 | - | - | Performance Award Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 6,477 | 39,737 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 1,645 | 9,776 | - | - | Restricted Stock Unit | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 111 | 6,078 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 377 | 1,131 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Dec 2021 | 377 | 10,623 (0%) | 0% | - | Ordinary Shares | |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 110.30 per share. | 19 Nov 2021 | 4,000 | 25,000 (0%) | 0% | 110.3 | 441,200 | Diodes Incorporated Common Stock |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 109.39 per share. | 15 Nov 2021 | 14,804 | 29,000 (0%) | 0% | 109.4 | 1,619,454 | Diodes Incorporated Common Stock |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.30 per share. | 15 Nov 2021 | 3,000 | 44,000 (0%) | 0% | 108.3 | 324,900 | Diodes Incorporated Common Stock |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.17 per share. | 15 Nov 2021 | 3,000 | 47,000 (0%) | 0% | 108.2 | 324,517 | Diodes Incorporated Common Stock |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 108.76 per share. | 15 Nov 2021 | 196 | 43,804 (0%) | 0% | 108.8 | 21,317 | Diodes Incorporated Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 220.00 per share. | 09 Nov 2021 | 9,446 | 24,095 (0%) | 0% | 220 | 2,078,120 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2021 | 9,446 | 33,260 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.24 per share. | 09 Nov 2021 | 9,446 | 33,541 (0%) | 0% | 73.2 | 691,825 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Sale of securities on an exchange or to another person at price $ 210.22 per share. | 25 Oct 2021 | 9,446 | 24,095 (0%) | 0% | 210.2 | 1,985,738 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Oct 2021 | 9,446 | 42,706 | - | - | Stock Option | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.24 per share. | 25 Oct 2021 | 9,446 | 33,541 (0%) | 0% | 73.2 | 691,825 | Common Stock |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2021 | 134 | 5,967 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 22 Sep 2021 | 3,666 | 10,246 (0%) | 0% | 160 | 586,560 | Ordinary Shares |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 959 | 0 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2021 | 959 | 13,912 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 09 Sep 2021 | 4,000 | 12,953 (0%) | 0% | 140 | 560,000 | Ordinary Shares |
| Diodes, Inc. | C.H. Chen | Director | Sale of securities on an exchange or to another person at price $ 96.65 per share. | 07 Sep 2021 | 50,000 | 50,000 (0%) | 0% | 96.6 | 4,832,265 | Diodes Incorporated Common Stock |
| Ambarella Inc | Chenming C. Hu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2021 | 1,508 | 1,508 | - | - | Restricted Stock Units | |
| Ambarella Inc | Chenming C. Hu | Director | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 01 Sep 2021 | 4,000 | 16,953 (0%) | 0% | 120 | 480,000 | Ordinary Shares |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 133 | 5,832 | - | - | Phantom Stock Unit | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 958 | 20,953 (0%) | 0% | - | Ordinary Shares | |
| Ambarella Inc | Chenming C. Hu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2021 | 958 | 959 | - | - | Restricted Stock Units | |
| Zoetis Inc - Ordinary Shar... | Heidi C. Chen | Executive Vice President | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Jun 2021 | 550 | 24,095 (0%) | 0% | 0 | Common Stock | |
| Diodes, Inc. | C.H. Chen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 4,250 | 98,629 (0%) | 0% | 0 | Diodes Incorporated Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges